Back to mobile site

Piper Sandler Reiterates Overweight Rating on Tectonic Therapeutics Inc. (TECX)

September 23, 2024 7:21 AM EDT Send to a Friend
Piper Sandler analyst Yasmeen Rahimi reiterated an Overweight rating and $76.00 price target on Tectonic Therapeutics Inc. (NASDAQ: TECX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login